Health AI Register Logo
ProductsPlatformsCompaniesNewsContact
Productsicobrain dm

Vendor source

Reviewed 11 May 2026

Completeness Comprehensive (81%)

icobrain dm

icometrix

icobrain dm aims to assists healthcare professionals in achieving a diagnosis of dementia and Alzheimer's disease (AD). icobrain dm uncovers abnormality patterns by: - Reporting sensitive brain volumetrics to allow the early detection of AD and other diseases causing dementia (whole brain and ventricular volumes and ratio). - Quantifying and tracking cortical brain volumes and asymmetries to help with the differential diagnosis of the most common dementia types (frontal, parietal, temporal, occipital, and hippocampal cortex) - Comparing volumes and volume changes to an age-and sex-matched normative reference population. - Visualizing abnormality patterns in an intuitive volume signature.

Supported by 6 papers

icobrain dm

Key Features

  • Brain region quantification
  • Brain volume changes
  • Report generation

General Information

Product name

icobrain dm

Company

Modality

CT, MR

Main task

Not specified

Subspeciality

Neuro

Disease targeted

Dementia

Regulatory Information

CE Certification

Pathway:

MDR

Class:

Class IIa

Verified by Health AI Register

FDA Certification

Pathway:

510(k) cleared

Class:

Class II

Verified by Health AI Register

Other certifications

Not specified

Evidence & Research

Peer-Reviewed Papers

Assessing the link between cerebellar volume and cognitive function in Alzheimer’s disease: a pilot study

Scientific Reports · Sep 2025

Automated Volumetric Software in Dementia: Help or Hindrance to the Neuroradiologist?

American Journal of Neuroradiology · Oct 2024

Towards validation in clinical routine: a comparative analysis of visual MTA ratings versus the automated ratio between inferior lateral ventricle and hippocampal volumes in Alzheimer’s disease diagnosis

Neuroradiology · Jan 2024

Combining semi-quantitative rating and automated brain volumetry in MRI evaluation of patients with probable behavioural variant of fronto-temporal dementia: an added value for clinical practise?

Neuroradiology · Mar 2023

Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer’s Disease in a Clinical Setting: A REMEMBER Study

Journal of Alzheimer's Disease · Jul 2021

Automated MRI volumetry as a diagnostic tool for Alzheimer's disease: Validation of icobrain dm

NeuroImage: Clinical · Mar 2020

Technical Specifications

Patient population age

Not specified

Input

For MRI: 3D T1 weighted image

Input format

DICOM

Output

Color-coded segmentation overlays, concise reports with reference statistics, pre-populated radiological reporting template

Output format

DICOM

Integration

Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration via AI marketplace or distribution platform

Deployment

Cloud-based

Trigger for analysis

Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload

Processing time

> 10 minutes

Population

MCI, dementia, Alzheimer's, FTD, DLB, ...

Market Presence

On market since

2018

AI Platforms

Blackford Analysis, GE Healthcare, Intrasense, Nuance, Philips Healthcare

Resellers

Not specified

Countries present

23

Paying clinical customers

>100

Research/test users

>300

Pricing Information

Pricing model

Subscription

Based on

Number of analyses

Source: Vendor | First published: May 26, 2024 | Last updated: May 11, 2026